IEX Stock Recent News

Reference is made to the announcement by IDEX Biometrics ASA (the "Company") on 12 December 2024 regarding the listing of Warrants A and Warrants B on Oslo Stock Exchange. Warrants B were exercisable between 31 March 2025 and 11 April 2025, and all Warrants B not exercised within such time lapsed without compensation to the holder.

IDEX Corporation (NYSE:IEX ) Q1 2025 Earnings Call May 1, 2025 9:00 AM ET Company Participants Jim Giannakouros - Investor Relations Eric Ashleman - President and Chief Executive Officer Abhi Khandelwal - Senior Vice President and Chief Financial Officer Conference Call Participants Mike Halloran - Baird Nathan Jones - Stifel Vlad Bystricky - Citigroup Joe Giordano - Cowen Bryan Blair - Oppenheimer Deane Dray - RBC Capital Markets Brett Linzey - Mizuho Matt Summerville - D.A. Davidson Operator Greetings.

IDEX Corporation designs, manufactures, and sells precise fluid and material handling solutions, operating in three segments. Growth by acquisitions is somewhat risky, but IDEX has done an excellent job of not overpaying for the companies it acquires. The company has a solid history of dividend growth, raising its dividend at a clip of 9% over the past decade.

Strength in the Health & Science Technologies segment aids IEX's first-quarter results.

The headline numbers for Idex (IEX) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Idex (IEX) came out with quarterly earnings of $1.75 per share, beating the Zacks Consensus Estimate of $1.64 per share. This compares to earnings of $1.88 per share a year ago.

IDEX Biometrics ASA will hold its 2025 annual general meeting on Wednesday 21 May 2025 at 14.00 hours CET as an online meeting. There is no physical attendance option. Shareholders may attend online by PC, smartphone or tablet.

IDEX Biometrics ASA annual report and remuneration report for 2024 are enclosed. IDEX Biometrics has also published its annual financial statements in European Single Electronic Format (ESEF), also attached to this notice. The auditor's report includes a matter of emphasis regarding going concern.

IDEX Corporation's stock has fallen 19.3% since last July, but I still rate it a 'hold' due to its high valuation. Revenue and profitability metrics for IDEX have been volatile, with mixed results across its three main business segments. Management's 2025 guidance suggests modest revenue growth and improved earnings, but economic uncertainty and potential tariff impacts remain concerns.

Reference is made to the share capital reduction in IDEX Biometrics ASA (the “Company”) resolved by the extraordinary general meeting on 11 April 2025, agenda item 3.